Several leading companies worldwide focus on the synthesis of complex medicinal APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Acetate. These substances present significant difficulties in process development due to their molecular intricacy. The suppliers of these APIs often employ advanced processes and adhere to strict regulatory guid